Medindia

X

Pfizer’s Eraxis Approved By The FDA

by Medindia Content Team on  February 22, 2006 at 4:20 PM Drug News   - G J E 4
Pfizer’s Eraxis Approved By The FDA
Pfizer Inc announced the approval of a new antifungal drug, for the treatment of bloodstream infection by the FDA. The new drug called Eraxis, is indicated in the treatment of candidemia, a hospital acquired fatal blood infection.
Advertisement

The improved performance of Eraxis compared to Diflucan, a currently employed anti-fungal treatment is said to have supported the approval. The drug can also be used in the treatment of infections caused by Candida (a fungus), intra-abdominal abscesses, fungal infection of the esophagus and peritonitis.

Advertisement
The acquisition of Vicuron Pharmaceuticals Inc. by Pfizer in September is said to have set stage for acquiring Eraxis. The company's share value in the afternoon fell down to 18% ($25.65) on the New York Stock Exchange.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All